Literature DB >> 32710892

Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.

Valeriya Gaysinskaya1, Susan E Stanley1, Soheir Adam2, Mary Armanios3.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is the most common of short telomere phenotypes. Familial clustering of IPF is common, but the genetic basis remains unknown in more than one-half of cases. We identified a 65-year-old man with familial IPF, short telomere length, and low telomerase RNA levels. He was diagnosed with a short telomere syndrome after developing hematologic complications post-lung transplantation, but no mutations were identified in a clinical testing pipeline. RESEARCH QUESTION: What is the molecular basis underlying the familial IPF and low telomerase RNA levels in this patient? STUDY DESIGN AND METHODS: We analyzed whole-genome sequence data and performed functional molecular studies on cells derived from the patient and his family.
RESULTS: We identified a previously unreported synonymous variant c.942G>A p.K314K in DKC1, the gene encoding the dyskerin ribonucleoprotein, which is required for telomerase RNA biogenesis. The mutation created a competing de novo exonic splicing enhancer, and the misspliced product was degraded by nonsense-mediated decay causing an overall dyskerin deficiency in mutation carriers. In silico tools identified other rare silent DKC1 variants that warrant functional evaluation if found in patients with short telomere-mediated disease.
INTERPRETATION: Our data point to silent mutation in telomere maintenance genes as a mechanism of familial pulmonary fibrosis. In contrast to DKC1 missense mutations, which primarily manifest in children as dyskeratosis congenita, hypomorphic mutations affecting dyskerin levels likely have a predilection to presenting in adults as pulmonary fibrosis.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bone marrow failure; lung transplantation; telomerase

Mesh:

Substances:

Year:  2020        PMID: 32710892      PMCID: PMC7768939          DOI: 10.1016/j.chest.2020.07.025

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  41 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.

Authors:  Tom J Vulliamy; Anna Marrone; Stuart W Knight; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

3.  Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.

Authors:  Erin M Parry; Jonathan K Alder; Xiaodong Qi; Julian J-L Chen; Mary Armanios
Journal:  Blood       Date:  2011-03-24       Impact factor: 22.113

4.  IPF lung fibroblasts have a senescent phenotype.

Authors:  Diana Álvarez; Nayra Cárdenes; Jacobo Sellarés; Marta Bueno; Catherine Corey; Vidya Sagar Hanumanthu; Yating Peng; Hannah D'Cunha; John Sembrat; Mehdi Nouraie; Swaroop Shanker; Chandler Caufield; Sruti Shiva; Mary Armanios; Ana L Mora; Mauricio Rojas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

5.  Telomere shortening in familial and sporadic pulmonary fibrosis.

Authors:  Jennifer T Cronkhite; Chao Xing; Ganesh Raghu; Kelly M Chin; Fernando Torres; Randall L Rosenblatt; Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

6.  Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.

Authors:  Susan E Stanley; Dustin L Gable; Christa L Wagner; Thomas M Carlile; Vidya Sagar Hanumanthu; Joshua D Podlevsky; Sara E Khalil; Amy E DeZern; Maria F Rojas-Duran; Carolyn D Applegate; Jonathan K Alder; Erin M Parry; Wendy V Gilbert; Mary Armanios
Journal:  Sci Transl Med       Date:  2016-08-10       Impact factor: 17.956

7.  Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene.

Authors:  Jonathan K Alder; Erin M Parry; Srinivasan Yegnasubramanian; Christa L Wagner; Lawrence M Lieblich; Robert Auerbach; Arleen D Auerbach; Sarah J Wheelan; Mary Armanios
Journal:  Hum Mutat       Date:  2013-09-11       Impact factor: 4.878

8.  Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening.

Authors:  Bridget D Stuart; Jungmin Choi; Samir Zaidi; Chao Xing; Brody Holohan; Rui Chen; Mihwa Choi; Pooja Dharwadkar; Fernando Torres; Carlos E Girod; Jonathan Weissler; John Fitzgerald; Corey Kershaw; Julia Klesney-Tait; Yolanda Mageto; Jerry W Shay; Weizhen Ji; Kaya Bilguvar; Shrikant Mane; Richard P Lifton; Christine Kim Garcia
Journal:  Nat Genet       Date:  2015-04-13       Impact factor: 41.307

9.  Diagnostic utility of telomere length testing in a hospital-based setting.

Authors:  Jonathan K Alder; Vidya Sagar Hanumanthu; Margaret A Strong; Amy E DeZern; Susan E Stanley; Clifford M Takemoto; Ludmila Danilova; Carolyn D Applegate; Stephen G Bolton; David W Mohr; Robert A Brodsky; James F Casella; Carol W Greider; J Brooks Jackson; Mary Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

View more
  9 in total

Review 1.  Genetics of human telomere biology disorders.

Authors:  Patrick Revy; Caroline Kannengiesser; Alison A Bertuch
Journal:  Nat Rev Genet       Date:  2022-09-23       Impact factor: 59.581

2.  Ovarian Failure Preceding Head and Neck Squamous Cell Carcinoma Identifies an Adult-Onset Cancer-Prone Syndrome Caused by FANCM Mutations.

Authors:  Paz J Vellanki; Emily A DeBoy; M Malek Bawadkji; Lynn Schuchter; Lisa Rooper; Ranee Mehra; Hyunseok Kang; Mary Armanios
Journal:  JCO Precis Oncol       Date:  2021-09-13

Review 3.  Telomere biology disorders.

Authors:  Michelle L W Kam; Trang T T Nguyen; Joanne Y Y Ngeow
Journal:  NPJ Genom Med       Date:  2021-05-28       Impact factor: 8.617

Review 4.  Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.

Authors:  Alexandre Garus; Chantal Autexier
Journal:  RNA       Date:  2021-09-23       Impact factor: 4.942

5.  Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad.

Authors:  Liqing Wang; Jianwei Li; Qiuhong Xiong; Yong-An Zhou; Ping Li; Changxin Wu
Journal:  Front Pediatr       Date:  2022-04-06       Impact factor: 3.418

Review 6.  Telomere-mediated lung disease.

Authors:  Jonathan K Alder; Mary Armanios
Journal:  Physiol Rev       Date:  2022-05-09       Impact factor: 46.500

7.  UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury.

Authors:  Xiaoyu Pan; Shuchun Chen; Xing Chen; Qingjuan Ren; Lin Yue; Shu Niu; Zelin Li; Ruiyi Zhu; Xiaoyi Chen; Zhuoya Jia; Ruoxi Zhen; Jiangli Ban
Journal:  J Diabetes Res       Date:  2022-06-13       Impact factor: 4.061

Review 8.  Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis.

Authors:  Hongbo Ma; Xuyi Wu; Yi Li; Yong Xia
Journal:  Front Pharmacol       Date:  2022-07-21       Impact factor: 5.988

9.  Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.

Authors:  Kristen E Schratz; Valeriya Gaysinskaya; Zoe L Cosner; Emily A DeBoy; Zhimin Xiang; Laura Kasch-Semenza; Liliana Florea; Pali D Shah; Mary Armanios
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.